Cancer Moonshot Initiatives

Abstract

DoD Cancer Moonshot 2 (CM2) is a mission assigned by the DoD to USUHS Murtha Cancer Center Research Program (MCCRP) as a mandate from the White House’s federal Cancer Moonshot part 2 (CM2) that was initiated in February 2022. CM2 is the next generation of the original federal cancer moonshot program initiated in 2016, for which the MCCRP is actively engaged in ongoing cancer studies. The DoD CM2 program is a new initiative with new translational research projects but can and will leverage the findings and capabilities that MCCRP has developed from the cancer moonshot 2016 program. In CM2, MCCRP will leverage DoD’s unique and additional capabilities to contribute to advancement of the seven priority areas of CM2 as designated by the White House. The MCCRP’s three new initiatives under the CM2 for DoD include: 1) Cancer Research and Clinical Trial Network; 2) Data Analytics (Integrated and pan-omic) and Molecular Cancer Epidemiology; and 3) DoD Serum Repository Projects surrounding environmental and toxin exposures in service members.

Open PDF

Document Details

Document Type
Project
Publication Date
Oct 01, 2024
Source ID
511_0603115DHA_2_0130_PB_2024

Tags

Readers

  • Defense Acquisition Program Management
  • Defense Technology Research and Development.
  • Mental Health of Military Veterans with Posttraumatic Stress Disorder (PTSD): Risk Factors, Prevalence, Symptoms, and Treatment.

Related Documents